Token Communities, Ltd. Announces New Head of China Operations

BRADENTON, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (Symbol: TKCM, “Token Communities” or the “Company”), today announced that the Company’s subsidiary Elements of Health and Wellness Inc. has retained Lorraine Law as the new head of operations to develop and manage the Greater China Market, including Hong Kong and Macau. Ms. Law has a very extensive background and experience in public company affairs and business development. She is fluent in Chinese, Cantonese and English, and graduated from Wuhan University, and has received accreditations from Boston University’s Business Administration Program, and ESC Clermont Graduate School of Management ( France ). Ms. Law will be assisting our CEO, David Chen to develop the Greater China Market, including recruiting new distributors, designing nationwide advertising campaign, government relations and operation compliance.

David Chen, CEO of the Company commented, “We are excited to have Ms. Law join the Company. We look forward to having someone with her expertise in the China Markets as we grow the Company.”

About the Company

Token Communities, Ltd., through its subsidiary Elements of Health and Wellness is actively engaged in the Health and Wellness Sector marketing and selling holistic and naturopathic products, including plant stem cell, natural supplements, cosmetic facial masks and more. We are developing an eCommerce platform to commence sales of all products.  

Forward-Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements using the words “hope,” “anticipate,” “may” and statements regarding the effects of the supplements referred to herein, and future plans and objectives of the Company, are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995) that involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.   Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Food and Drug Administration Disclosure

The products featured in this release are not for use by or sale to persons under the age of 12. These products should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using these and any supplemental product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

Investor Contact: David Chen, Chairman, CEO: